This piece by News Editor Gregory Seay originally appeared in the Hartford Business Journal December 13, 2016.
Michael Weiner, a serial entrepreneur, inventor and author, is the Connecticut United for Research Excellence’s (CURE) 2016 “Entrepreneur of the Year.”
Weiner, vice president of molecular sciences at Abcam in Branford, was introduced as this year’s honoree Tuesday night at CURE’s annual holiday event at Alexion Pharmaceuticals Inc.’s headquarters in New Haven.
In his nominations, peers hailed Weiner as “a creative and prescient innovator” and “a self-starter with business as well as scientific acumen.” Abcam provides protein research tools to life scientists.
“We are honored to recognize a serial entrepreneur with the rare combination of deep science and business savvy,” CURE CEO Susan Froshauer said.
He founded and sold three companies, two of which were based in Branford: Affomix, acquired by Illumina in 2010; and AxioMx, acquired by Abcam in 2015.
CURE is a bioscience cluster that promotes sustainable collaboration between Connecticut’s health and bioscience communities.
Learn more about CURE at cureconnect.org.